720 related articles for article (PubMed ID: 15113361)
1. Review article: Osteoporosis and inflammatory bowel disease.
Bernstein CN; Leslie WD
Aliment Pharmacol Ther; 2004 May; 19(9):941-52. PubMed ID: 15113361
[TBL] [Abstract][Full Text] [Related]
2. Skeletal morbidity in inflammatory bowel disease.
van Hogezand RA; Hamdy NA
Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
[TBL] [Abstract][Full Text] [Related]
3. Review article: bone disease in inflammatory bowel disease.
Schulte CM
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():43-9. PubMed ID: 15352893
[TBL] [Abstract][Full Text] [Related]
4. Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease.
Bernstein CN; Bector S; Leslie WD
Am J Gastroenterol; 2003 Nov; 98(11):2468-73. PubMed ID: 14638350
[TBL] [Abstract][Full Text] [Related]
5. Therapy insight: Osteoporosis in inflammatory bowel disease--advances and retreats.
Bernstein CN; Leslie WD
Nat Clin Pract Gastroenterol Hepatol; 2005 May; 2(5):232-9. PubMed ID: 16265206
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of osteoporosis in inflammatory bowel disease.
Reinshagen M; Von Tirpitz C
Minerva Med; 2004 Dec; 95(6):481-7. PubMed ID: 15785433
[TBL] [Abstract][Full Text] [Related]
7. Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment.
Katz S
Rev Gastroenterol Disord; 2006; 6(2):63-71. PubMed ID: 16699475
[TBL] [Abstract][Full Text] [Related]
8. [Osteoporosis associated with inflammatory bowel diseases].
Miheller P; Tóth M; Pregun I; Tulassay Z
Orv Hetil; 2004 May; 145(20):1045-51. PubMed ID: 15202326
[TBL] [Abstract][Full Text] [Related]
9. [Low bone mineral density in children with Crohn's disease].
Bourges O; Dorgeret S; Alberti C; Hugot JP; Sebag G; Cézard JP
Arch Pediatr; 2004 Jul; 11(7):800-6. PubMed ID: 15234375
[TBL] [Abstract][Full Text] [Related]
10. Management of bone loss in inflammatory bowel disease.
Lichtenstein GR
Semin Gastrointest Dis; 2001 Oct; 12(4):275-83. PubMed ID: 11726081
[TBL] [Abstract][Full Text] [Related]
11. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
Bernstein CN; Seeger LL; Sayre JW; Anton PA; Artinian L; Shanahan F
J Bone Miner Res; 1995 Feb; 10(2):250-6. PubMed ID: 7754804
[TBL] [Abstract][Full Text] [Related]
12. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha haplotype is strongly associated with bone mineral density in patients with Crohn's disease.
Lee N; Fowler E; Mason S; Lincoln D; Taaffe DR; Radford-Smith G
J Gastroenterol Hepatol; 2007 Jun; 22(6):913-9. PubMed ID: 17565648
[TBL] [Abstract][Full Text] [Related]
14. [Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients].
Boubaker J; Feki M; Hsairi M; Fekih M; Kaabachi N; Filali A; Mebazaa A
Gastroenterol Clin Biol; 2003 Oct; 27(10):901-7. PubMed ID: 14631305
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of osteoporosis in patients with inflammatory bowel disease.
Valentine JF; Sninsky CA
Am J Gastroenterol; 1999 Apr; 94(4):878-83. PubMed ID: 10201450
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
Vestergaard P
Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
[TBL] [Abstract][Full Text] [Related]
17. The frequency of osteoporosis screening in men with inflammatory bowel disease.
Nguyen HD; Bakshi AK; Borum ML
Am J Mens Health; 2010 Mar; 4(1):71-4. PubMed ID: 19477762
[TBL] [Abstract][Full Text] [Related]
18. A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software.
Firouzi F; Rashidi M; Hashemi S; Kangavari M; Bahari A; Daryani NE; Emam MM; Naderi N; Shalmani HM; Farnood A; Zali M
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1075-81. PubMed ID: 17998832
[TBL] [Abstract][Full Text] [Related]
19. A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease.
Henderson S; Hoffman N; Prince R
Am J Gastroenterol; 2006 Jan; 101(1):119-23. PubMed ID: 16405543
[TBL] [Abstract][Full Text] [Related]
20. Negative impact of Crohn's disease on bone mineral mass.
Thodis E; Rossos P; Habal F; Oreopoulos D
J Musculoskelet Neuronal Interact; 2003 Sep; 3(3):246-50. PubMed ID: 15758348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
